Showing results (1671-1680 of 1,738) with videos related to

Sort By:
Pageof 174
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2021
Tipifarnib in Head and Neck Squamous Cell Carcinoma With <i>HRAS</i> MutationsAlan L Ho, Irene Brana, Robert Haddad, et al.
Circulation. Cardiovascular Interventions|March 30, 2025
Effect of Red Blood Cell Transfusion Strategy on Clinical Outcomes Among Patients With Acute Myocardial Infarction Undergoing Revascularization: A Prespecified Analysis of the MINT TrialSunil V Rao, Maria Mori Brooks, Helen E A D'Agostino, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2018
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersLara A Dunn, Eric J Sherman, Shrujal S Baxi, et al.
Neurology|August 1, 2024
Sex Differences in the Risk of Stroke Associated With Traditional and Non-Traditional Factors in a US Cohort of People With HIV InfectionFelicia C Chow, Robin M Nance, Kyra Becker, et al.
Cancer Research|June 20, 2023
Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR ActivityAlison E Smith, Stacia Chan, Zhiyong Wang, et al.
Cancer Research|February 8, 2023
Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck CancerSankar Jagadeeshan, Manu Prasad, Mai Badarni, et al.
Inflammatory Bowel Diseases|December 30, 2021
Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and WestJeanine H C Arkenbosch, Joyce W Y Mak, Jacky C L Ho, et al.
Journal of Proteomics|February 13, 2009
Bothrops insularis venomics: a proteomic analysis supported by transcriptomic-generated sequence dataRichard H Valente, Patrícia R Guimarães, Magno Junqueira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancerJ S Chen, C Hsu, N J Chiang, et al.
JAMA Network Open|November 11, 2022
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyIrini Youssef, Jennifer Yoon, Nader Mohamed, et al.
Pageof 174